Previous Article | Next Article ![]()
Journal of Virology, March 2001, p. 2468-2471, Vol. 75, No. 5
Laboratoire d'ImmunoPharmacologie Structurale,
Institut de Pharmacologie et de Biologie Structurale, CNRS, 31400 Toulouse, France
Received 29 August 2000/Accepted 30 November 2000
Infection of H-2b mice with
lymphocytic choriomeningitis virus (LCMV) generates an
H-2Db-restricted cytotoxic T-lymphocyte (CTL) response
whose subdominant component is directed against the GP92-101
(CSANNSHHYI) epitope. The aim of this study was to identify the
functional parameters accounting for this subdominance. We found that
the two naturally occurring (genetically encoded and
posttranslationally modified) forms of LCMV GP92-101 were immunogenic,
did not act as T-cell antagonists, and bound efficiently to but were
unable to form stable complexes with H-2Db, a crucial
factor for immunodominance. Thus, the H-2Db-restricted
subdominant CTL response to LCMV resulted not from altered T-cell
activation but from impaired major histocompatibility complex
presentation properties.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2468-2471.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular and Functional Dissection of the
H-2Db-Restricted Subdominant Cytotoxic T-Cell Response to
Lymphocytic Choriomeningitis Virus

*
Corresponding author. Mailing address: Laboratoire
d'ImmunoPharmacologie Structurale, Institut de Pharmacologie et de
Biologie Structurale, CNRS, 205 route de Narbonne, 31400 Toulouse,
France. Phone: 33-561-175-530. Fax: 33-561-175-532. E-mail:
gairin{at}ipbs.fr.
Present address: INSERM U395, CHU Purpan, 31059 Toulouse Cedex, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»